Literature DB >> 20921896

Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics.

Claire Julian-Reynier1, Anne-Déborah Bouhnik, Emanuelle Mouret-Fourme, Marion Gauthier-Villars, Pascaline Berthet, Christine Lasset, Jean-Pierre Fricker, Olivier Caron, Paul Gesta, Elisabeth Luporsi, Laurence Faivre, Michel Longy, Laurence Gladieff, Marc Frenay, Héléne Dreyfus, Hagay Sobol, Philippe Vennin, Catherine Nogués.   

Abstract

PURPOSE: To investigate the medical and psychosocial factors determining the time to prophylactic surgery of unaffected women carriers of a deleterious BRCA1/2 mutation.
METHODS: Prospective study on a French national cohort of unaffected BRCA1/2 carriers (N = 244); multivariate Cox proportional hazard modeling.
RESULTS: Median follow-up time was 2.33 years (range, 0.04-6.84 years). Time to surgery was shorter when the psychological impact of BRCA1/2 result disclosure was stated to be higher (P ≤ 0.01). Those who intended to opt for prophylactic surgery before being tested did so faster and more frequently after test disclosure than those who were undecided/opposed. The older the women were, the faster their uptake of risk-reducing salpingo-oophorectomy (adjusted hazard ratio >2.95; P < 0.001) was; the uptake of those with at least two children was also faster (adjusted hazard ratio = 2.51; [1.38-4.55]). Those who opted most quickly for risk-reducing mastectomy more frequently had a younger child at the time of testing (adjusted hazard ratio = 4.63 [1.56-13.74]). Time to surgery was shorter when there was a first-degree relative with ovarian/breast cancer (P ≤ 0.01).
CONCLUSION: Time to prophylactic surgery depends on the stated psychological impact of disclosure and on women's cognitive anticipation of surgery after adjusting on sociodemographic characteristics.

Entities:  

Mesh:

Year:  2010        PMID: 20921896     DOI: 10.1097/GIM.0b013e3181f48d1c

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  17 in total

1.  French women's breast self-examination practices with time after undergoing BRCA1/2 genetic testing.

Authors:  C Maheu; T Apostolidis; A Petri-Cal; E Mouret-Fourme; M Gauthier-Villars; C Lasset; P Berthet; J-P Fricker; O Caron; E Luporsi; L Gladieff; C Noguès; C Julian-Reynier
Journal:  Fam Cancer       Date:  2012-06       Impact factor: 2.375

2.  Predictors of risk-reducing surgery intentions following genetic counseling for hereditary breast and ovarian cancer.

Authors:  Mary Kathleen Ladd; Beth N Peshkin; Leigha Senter; Shari Baldinger; Claudine Isaacs; Hannah Segal; Samantha Philip; Chloe Phillips; Kate Shane; Aimee Martin; Veronique Weinstein; Robert Pilarski; Joanne Jeter; Kevin Sweet; Bonnie Hatten; Elisabeth J Wurtmann; Shanda Phippen; Della Bro; Marc D Schwartz
Journal:  Transl Behav Med       Date:  2020-05-20       Impact factor: 3.046

3.  Impact of BRCA1/2 mutation on young women's 5-year parenthood rates: a prospective comparative study (GENEPSO-PS cohort).

Authors:  Julien Mancini; Emmanuelle Mouret-Fourme; Catherine Noguès; Claire Julian-Reynier
Journal:  Fam Cancer       Date:  2015-06       Impact factor: 2.375

4.  The evolution of personalized cancer genetic counseling in the era of personalized medicine.

Authors:  Hetal S Vig; Catharine Wang
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

Review 5.  Systemic Barriers to Risk-Reducing Interventions for Hereditary Cancer Syndromes: Implications for Health Care Inequities.

Authors:  Kathleen F Mittendorf; Sarah Knerr; Tia L Kauffman; Nangel M Lindberg; Katherine P Anderson; Heather Spencer Feigelson; Marian J Gilmore; Jessica Ezzell Hunter; Galen Joseph; Stephanie A Kraft; Jamilyn M Zepp; Sapna Syngal; Benjamin S Wilfond; Katrina A B Goddard
Journal:  JCO Precis Oncol       Date:  2021-11-03

6.  The effect of referral for genetic counseling on genetic testing and surgical prevention in women at high risk for ovarian cancer: Results from a randomized controlled trial.

Authors:  Charles W Drescher; J David Beatty; Robert Resta; M Robyn Andersen; Kate Watabayashi; Jason Thorpe; Sarah Hawley; Hannah Purkey; Jessica Chubak; Nancy Hanson; Diana S M Buist; Nicole Urban
Journal:  Cancer       Date:  2016-07-22       Impact factor: 6.860

7.  Psychosocial factors and uptake of risk-reducing salpingo-oophorectomy in women at high risk for ovarian cancer.

Authors:  Bettina Meiser; Melanie A Price; Phyllis N Butow; Janan Karatas; Judy Wilson; Louise Heiniger; Brandi Baylock; Margaret Charles; Sue-Anne McLachlan; Kelly-Anne Phillips
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

8.  Adherence to Recommended Risk Management among Unaffected Women with a BRCA Mutation.

Authors:  Adam H Buchanan; Corrine I Voils; Joellen M Schildkraut; Catherine Fine; Nora K Horick; P Kelly Marcom; Kristi Wiggins; Celette Sugg Skinner
Journal:  J Genet Couns       Date:  2016-06-06       Impact factor: 2.537

9.  Patient-Reported Satisfaction after Prophylactic Operations of the Breast.

Authors:  Katja Keller; Cornelia Meisel; Nannette Grübling; Andrea Petzold; Pauline Wimberger; Karin Kast
Journal:  Breast Care (Basel)       Date:  2019-02-15       Impact factor: 2.860

10.  Development of decision aids for female BRCA1 and BRCA2 mutation carriers in Germany to support preference-sensitive decision-making.

Authors:  Sibylle Kautz-Freimuth; Marcus Redaèlli; Kerstin Rhiem; Andrea Vodermaier; Lisa Krassuski; Kathrin Nicolai; Miriam Schnepper; Violetta Kuboth; Julia Dick; Vera Vennedey; Regina Wiedemann; Rita Schmutzler; Stephanie Stock
Journal:  BMC Med Inform Decis Mak       Date:  2021-06-05       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.